Immediate Impact
21 standout
Citing Papers
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
2025 Standout
Recent advances in self-targeting natural product-based nanomedicines
2025 Standout
Works of Andreas Brühschwein being referenced
A pilot trial of doxorubicin containing phosphatidyldiglycerol based thermosensitive liposomes in spontaneous feline soft tissue sarcoma
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Andreas Brühschwein | 114 | 110 | 53 | 39 | 282 | |
| Teppei Kanda | 137 | 63 | 23 | 42 | 291 | |
| Mamiko Seki | 100 | 140 | 93 | 29 | 298 | |
| Lisa S. Klopp | 65 | 157 | 90 | 19 | 332 | |
| D. Lorinson | 163 | 185 | 34 | 22 | 314 | |
| Antonio Di Meo | 54 | 122 | 50 | 40 | 286 | |
| Mehmet Kamil Ocal | 95 | 119 | 66 | 31 | 277 | |
| Helena Rylander | 147 | 125 | 39 | 25 | 284 | |
| Cristian de la Fuente | 33 | 54 | 85 | 31 | 287 | |
| Marjorie Milne | 35 | 54 | 71 | 24 | 276 | |
| Kathleen Linn | 93 | 136 | 40 | 29 | 258 |
All Works
Login with ORCID to disown or claim papers
Loading papers...